NutraFuels Inc. (OTCQB:NTFU) Utilizes Nanotechnology for Its CBD-infused Products

To read this press release on visit:

NutraFuels Inc. (OTCQB:NTFU) Utilizes Nanotechnology for Its CBD-infused Products

Coconut Creek, FL, Dec. 10, 2018 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE — NutraFuels, Inc. (“NTFU” or the “Company”), Nutraceutical & CBD Manufacturer & Distributor, announces its use of Nanotechnology in its CBD-infused line of products distributed under its NutraHempCBD brand.

NTFU’s nanotechnology is designed to provide optimal absorption into the body of NTFU’s CBD-infused formulations. Nanotechnology refers to dealing with matter on a very small scale. Nanotechnology allows the smaller cannabinoid particles to be in their most bio-active form for fast absorption and high potency.

“We believe that our proprietary processing utilizing nanotechnology allows for us to create superior products with enhanced bioavailability,” said Edgar Ward, CEO, and Founder of NutraFuels Inc., “We believe that nanotechnology and our enhanced delivery system allows us to give our customers the most effective and efficient delivery system.”

According to Andrij Holian of the Center for Environmental Health Sciences Biomedical and Pharmaceutical Sciences, “Nanoparticles have become a significant interest as a drug delivery system due to their small size and large surface area.”

NutraFuels Inc., a publicly held company traded on the OTCQB under the ticker symbol NTFU, is a nutraceutical company with a line of CBD-infused products known by its in-house brand, NutraHempCBD. Using premium CBD hemp oil, its formulations are designed to promote overall health and wellness. NutraHempCBD products are intended for daily use with observed health benefits including anti-stress, anti-inflammation, calmness to sleep and stay asleep.

NutraHempCBD uses its specialty process to decrease the particle size and uses nano nanoemulsion in its products. For example, its Joint and Pain Balm aids in the alleviation pain with a silky and soothing formulation. Studies suggest that the key ingredient, CBD, may reduce inflammation while interacting with neurotransmitters. The CBD-infused Face Cream is made with Shea Butter and works to maintain elasticity of the delicate facial tissue. CBD studies have shown anti-inflammatory properties as well as a reduction in acne. For a full list of products including Nutrahemp CBD oral sprays, the day and nighttime formulas, and NutraPet oil visit its website.

NutraFuels, Inc is a fully reporting company with a class of securities registered with the U.S. Securities & Exchange Commission (“SEC”). As reported in its Form 8-K filed with the SEC on November 13, 2018, NTFU recently announced its financial results for the three (3) and nine (9) month period ended September 30, 2018 with revenue of $1,062,146 and $2,870,462 respectively compared to $652,385 and $1,027,727 for the three (3) and nine (9) month period ended September 30, 2017. NTFU’s filings with the SEC can be viewed at NTFU’s CBD products and information about the company’s direct sales program can be found online at and by following the company on Instagram.

Forward-Looking Statements
This communications contains statements of a forward-looking nature. These statements are made under the “safe harbor” provisions of the U.S. Private Securities Litigation Reform Act of 1995. You can identify these forward-looking statements by words or phrases such as “may,” “will,” “except,”, “intends”, “anticipate,” “aim,” “estimate,” “plan,” “believe,” “is/are likely to,” “future” or other similar expressions. NutraFuels, Inc. (“NTFU” or the “Company”) has based these forward-looking statements largely on the Company’s current expectations and projections about future events and financial trends that the Company believes may affect Company’s financial condition, results of operations, business strategy and financial needs. There is no assurance that Company’s current expectations and projections are accurate. All forward-looking statements in this press release are based on information available to the Company on the date hereof. These statements involve known and unknown risks, uncertainties and other factors that may cause the Company’s actual results to differ materially from those implied by the forward-looking statements. More detailed information about these risk factors are set forth in the Company’s filings with the Securities and Exchange Commission, including, but not limited to, those risks and uncertainties listed in the Section entitled “Risk Factors,” in the Company’s Annual Report on Form 10-K for the year ended December 31, 2017 filed with the Securities and Exchange Commission on April 17, 2018. The Company operates in a rapidly evolving environment. New risk factors emerge from time to time, and it is impossible for the Company’s management to predict all risk factors, nor can the Company assess the impact of all factors on Company’s business or the extent to which any factor, or combination of factors, may cause actual results to differ from those contained in any forward-looking statement. The Company does not undertake any obligation to update or revise the forward-looking statements except as required under applicable law.